For years, clinical laboratories have operated under the constant threat of annual reductions to reimbursements for the services they provide. Ongoing reductions to the Clinical Laboratory Fee Schedule have been a particular area of concern that continues to drive down payer rates across the industry.
We recently welcomed Erin Morton and Meghan Riley, policy advocates for the National Independent Laboratory Association, to provide a detailed look at clinical lab cuts over time and how Congress can permanently address the issue of unsustainable reimbursements. Experts from our RCM Solutions team will also be joining the call to share their view of the current reimbursement landscape and offer actionable steps labs can take now to safeguard their revenue amidst these changes.
Jump to:
-Where PAMA/Clinical Lab Cuts Stand Today (7:48)
-Core Challenges to Installing a Permanent Fix (12:29)
-Saving Access to Lab Services Act and Ongoing Hurdles (15:26)
-Next Steps and Action Plans (20:55)
-Other Issues Impacting Lab Reimbursement (23:46)
-Documentation Issues in Medical Billing (28:23)
-KPIs (32:20)
-Preparing for Audits (43:58)
#PAMA #laboratory #clinicallaboratory #medicalbillingandcoding #congress #revenue